186 related articles for article (PubMed ID: 30821562)
1. Adjunctive gentamicin did not improve outcome of enterococcal bacteraemia in neutropenic patients: a propensity scored matched study.
Jent P; Thalmann L; Pabst T; Droz S; Sendi P
Infect Dis (Lond); 2019 Jun; 51(6):409-416. PubMed ID: 30821562
[TBL] [Abstract][Full Text] [Related]
2. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
[TBL] [Abstract][Full Text] [Related]
3. Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy.
Suppli M; Aabenhus R; Harboe ZB; Andersen LP; Tvede M; Jensen JU
Clin Microbiol Infect; 2011 Jul; 17(7):1078-83. PubMed ID: 20946408
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
Ombandza-Moussa E; Schlegel L; Vekhoff A; Gerbal R; Marie JP; Bouvet A
Pathol Biol (Paris); 2002 Apr; 50(3):169-77. PubMed ID: 11980330
[TBL] [Abstract][Full Text] [Related]
5. Australian Enterococcal Sepsis Outcome Programme annual report, 2013.
Coombs GW; Pearson JC; Daly DA; Le TT; Robinson JO; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E320-6. PubMed ID: 25631594
[TBL] [Abstract][Full Text] [Related]
6. A febrile neutropenic patient with Enterococcus gallinarum sepsis treated with daptomycin and gentamicin.
Barber GR; Lauretta J; Saez R
Pharmacotherapy; 2007 Jun; 27(6):927-32. PubMed ID: 17542774
[TBL] [Abstract][Full Text] [Related]
7. Enterococcal bacteraemia: epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance.
Shaked H; Carmeli Y; Schwartz D; Siegman-Igra Y
Scand J Infect Dis; 2006; 38(11-12):995-1000. PubMed ID: 17148067
[TBL] [Abstract][Full Text] [Related]
8. Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance.
Jang HC; Lee S; Song KH; Jeon JH; Park WB; Park SW; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
J Korean Med Sci; 2010 Jan; 25(1):3-8. PubMed ID: 20052340
[TBL] [Abstract][Full Text] [Related]
9. The rise of ampicillin-resistant Enterococcus faecium high-risk clones as a frequent intestinal colonizer in oncohaematological neutropenic patients on levofloxacin prophylaxis: a risk for bacteraemia?
Sánchez-Díaz AM; Cuartero C; Rodríguez JD; Lozano S; Alonso JM; Rodríguez-Domínguez M; Tedim AP; Del Campo R; López J; Cantón R; Ruiz-Garbajosa P
Clin Microbiol Infect; 2016 Jan; 22(1):59.e1-59.e8. PubMed ID: 26321668
[TBL] [Abstract][Full Text] [Related]
10. β-lactam antibiotics vs. vancomycin for the early treatment of enterococcal bacteraemia: A retrospective cohort study.
Petersiel N; Bitterman R; Manaa A; Nashashibi L; Moskovich O; Geffen Y; Polak D; Braun E; Neuberger A; Paul M
Int J Antimicrob Agents; 2019 Jun; 53(6):761-766. PubMed ID: 30954636
[TBL] [Abstract][Full Text] [Related]
11. Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance.
Bae KS; Shin JA; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
Infection; 2019 Jun; 47(3):417-424. PubMed ID: 30565009
[TBL] [Abstract][Full Text] [Related]
12. Increasing trend in enterococcal bacteraemia and vancomycin resistance in a tertiary care hospital in Croatia, 2017-2021.
Todorić Z; Majdandžić I; Keretić Kregar T; Herljević Z; Ćorić M; Lešin J; Kuliš T; Mareković I
Infect Dis (Lond); 2023 Jan; 55(1):9-16. PubMed ID: 36240424
[TBL] [Abstract][Full Text] [Related]
13. Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study.
Echeverria-Esnal D; Sorli L; Prim N; Conde-Estévez D; Mateu-De Antonio J; Martin-Ontiyuelo C; Horcajada JP; Grau S
Int J Antimicrob Agents; 2019 Nov; 54(5):572-578. PubMed ID: 31476435
[TBL] [Abstract][Full Text] [Related]
14. [Study of a cohort of patients with Enterococcus spp. Bacteraemia. Risk factors associated to high-level resistance to aminoglycosides].
García-Vázquez E; Albendín H; Hernández-Torres A; Canteras M; Yagüe G; Ruiz J; Gómez J
Rev Esp Quimioter; 2013 Sep; 26(3):203-13. PubMed ID: 24080886
[TBL] [Abstract][Full Text] [Related]
15. Enterococcal bacteraemia: a prospective study of 125 episodes.
Gray J; Marsh PJ; Stewart D; Pedler SJ
J Hosp Infect; 1994 Jul; 27(3):179-86. PubMed ID: 7963458
[TBL] [Abstract][Full Text] [Related]
16. Infectious Diseases Consultation Improves Treatment and Decreases Mortality by Enterococcal Bacteremia in Children.
Furuichi M; Furuichi M; Horikoshi Y; Miyairi I
Pediatr Infect Dis J; 2018 Sep; 37(9):856-860. PubMed ID: 29384980
[TBL] [Abstract][Full Text] [Related]
17. Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases.
Sandoe JA; Witherden IR; Au-Yeung HK; Kite P; Kerr KG; Wilcox MH
J Antimicrob Chemother; 2002 Oct; 50(4):577-82. PubMed ID: 12356804
[TBL] [Abstract][Full Text] [Related]
18. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
[TBL] [Abstract][Full Text] [Related]
19. Low-dose Gentamicin for Uncomplicated Enterococcus faecalis Bacteremia May be Nephrotoxic in Children.
Ibrahim SL; Zhang L; Brady TM; Hsu AJ; Cosgrove SE; Tamma PD
Clin Infect Dis; 2015 Oct; 61(7):1119-24. PubMed ID: 26082503
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF; Friedrich LV; Yankelev S; Lamp KC
Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
